Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, Non-Hodgkin

Explore clinical trials studying Lymphoma, Non-Hodgkin. Study availability and eligibility vary by location and protocol.

2,778 public trials 699 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, Non-Hodgkin trial results

Completed

A Phase 1, Multicenter, Open-Label Study to Evaluate the Effect of Mild or Moderate Hepatic Impairment on the Multiple-Dose Pharmacokinetics of Ozanimod

NCT04639115

Conditions
Digestive System Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • University of Miami Miller School of Medicine Miami, Florida, United States
  • Orlando Clinical Research Center OCRC Orlando, Florida, United States
  • The Texas Liver Institute San Antonio, Texas, United States
View Trial Details
Completed

Phase II Randomized Study With R-DHAP +/- Bortezomib as Induction Therapy in Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL) Patients Eligible to Transplantation. BR-DHAP Versus R-DHAP.

NCT01805557

Conditions
Diffuse Large B-cell Lymphoma Recurrent, Diffuse Large B-cell Lymphoma Refractory, Hemic and Lymphatic Diseases, +10 more
Locations
  • Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori-Ematologia Meldola, Forlì-Cesena, Italy
  • Clinica Humanitas Rozzano, Milano, Italy
  • ASST Grande Ospedale Metropolitano Niguarda - SC Ematologia Milan, MI, Italy
  • CRO Aviano Aviano, Pordenone, Italy
View all 24 locations
View Trial Details
Completed

PDR001 Plus LAG525 for Patients With Advanced Solid and Hematologic Malignancies

NCT03365791

Conditions
Adenocarcinoma Of Esophagus, Advanced Well-differentiated Neuroendocrine Tumors, Bronchial Neoplasms, +28 more
Locations
  • California Pacific Medical Center Drug Shipment (2) San Francisco, California, United States
  • Hematology Oncology Associates of the Treasure Coast Port Saint Lucie, Florida, United States
  • University Cancer and Blood Center, LLC Athens, Georgia, United States
  • Northwestern University Medical School Chicago, Illinois, United States
View all 20 locations
View Trial Details
Completed

Optimal Dose Finding Study ABT-199 and Ibrutinib in MCL

NCT02419560

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations
  • City of Hope Duarte, California, United States
  • Winship Cancer Institute, Emory University Atlanta, Georgia, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • University of Virginia Charlottesville, Virginia, United States
View Trial Details
Completed

Evaluation of the Combination of Romidepsin and Carfilzomib in Relapsed/Refractory Peripheral T Cell Lymphoma Patients

NCT03141203

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • Queen Elizabeth Hospital Birmingham, United Kingdom
  • St James's University Hospital Leeds, United Kingdom
  • Leicester Royal Infirmary Leicester, United Kingdom
  • Clatterbridge Cancer Centre Liverpool, United Kingdom
View all 13 locations
View Trial Details

Related conditions